TABLE 1

Primers used for mutant construction and cloning


Name

Sequence

Features
m-h2-1e2tF 5′-CAGGAGGGCAGCACCCTTAATTCTCATCTCCTGCC-3′a QEGST peptide
m-h2-1e2tR 5′-GGTGCTGCCCTCCTGTGTCAAGCAGAAAATGCA-3′a QEGST rc peptide
m-h2-1w4tF 5′-AGACCCCACGCCGGCTTTCTTAATTCTCATCTCCTG-3′a PHAG peptide
m-h2-1w4tR 5′-AAAGCCGGCGTGGGGTCTCTCTTCTGTCAAGCAGA-3′a PHAG rc peptide
m-h2-2bszF 5′-GACAGAAGCCAACGACCACCTTAATTCTCATCTCCTGCC-3′a ANDH peptide
m-h2-2bszR 5′-AAGGTGGTCGTTGGCTTCTGTCAAGCAGAAAATGC-3′a ANDH rc peptide
m-h2-CustF 5′-ACAAGCGACGCCAGCGACCTTAATTCTCATCTCCTGCC-3′a SDGSD peptide
m-h2-CustR 5′-GTCGCTGGCGTCGCTTGTCAAGCAGAAAATGCA-3′a SDGSD rc peptide
3d-h2-1e2tF 5′-ATCCACCACGAGCACCACCAAAAAATATACTTATTTACGC-3′a HHEH peptide
3d-h2-1e2tR 5′-GTGGTGCTCGTGGTGGATTTGGTCCAGGTACCAG-3′a HHEH rc peptide
3d-h2-1w4tF 5′-ATCGGCAGAAGCGGCCACCAAAAAATATACTTATTTACGC-3′a GRSG peptide
3d-h2-1w4tR 5′-GTGGCCGCTTCTGCCGATTTGGTCCAGGTACCAG-3′a GRSG rc peptide
3d-h2-2bszF 5′-ATCAGGGGCGGCAAACACCAAAAAATATACTTATTTACG-3′a GG peptide
3d-h2-2bszR 5′-GTGTTTGCCGCCCCTGATTTGGTCCAGGTAC-3′a GG rc peptide
3d-h2-CustF 5′-ATCGGCGGCAGCGGCCACCAAAAAATATACTTATTTACGC-3′a CGSG peptide
3d-h2-CustR 5′-GCCGCTGCCGCCGATTTGGTCCAGGTACCA-3′a GGSG rc peptide
hNat2EcoRI-F 5′-ATGCGAGAATTCATGGACATTGAAGCATATTTTGAAAGAATT-3′b PCR, EcoR1
hNat2HindIII-R 5′-ATGCGAAAGCTTAAGGGTTTATTTTGTTCCTTATTCTAAAT-3′b PCR, HindIII
pKK-F 5′-TTATCAGACCGCTTCTGCGT-3′ PCR, Fwd-Seq
h2-Seq1F 5′-CCGGGGTGGGTGGTGTCT-3′ Fwd-Seq
h2-Seq2F 5′-CACCTTCTCCTGCAGGTGACCAT-3′ Fwd-Seq
h2-Seq3F 5′-TTTGGTGGGCTTCATCCTCA-3′ Fwd-Seq
pKK-R 5′-GCTGTTGACAATTAATCATCGG-3′ PCR, Rev-Seq
h2-Seq1R 5′-CAACCTCTTCCTCAGTGAGAG-3′ Rev-Seq
h2-Seq2R 5′-ACATCTGGGAGGAGCTTCCA-3′ Rev-Seq
h2-Seq3R
5′-TGACCTGGAGACACCACCCA-3′
Rev-Seq
  • rc, reverse complement; Fwd-Seq, forward sequence; Rev-Seq, reverse sequence.

  • a Underline indicates turn residue codons.

  • b Underline indicates restriction site.